News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers have, for the first time, identified two separate populations of immune cells in the liver, which will help doctors understand the mechanisms by which the liver is damaged and repaired and may lead to future drug therapies.
US researchers have found that three types of leukaemias are all caused by acquired mutations that alter a specific enzyme controlling blood cell proliferation. Identifying the genetic malfunction may give rise to a targeted therapy, similar to...
The wealth of new targets identified from genomics and the discoveries made in the molecular pathology of cancer will give rise to a new generation of cancer treatment, moving one step closer to individualised, target therapy.